CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

What is the Role of Technology in Solving FDA Compliance Challenges?

By Life Sciences Review | Friday, October 30, 2020
Tweet

One of the biggest threats to the growth story of the Indian Pharmaceutical Industry today is non-compliance.


Fremont, CA: The cost of a single non-compliance event is tens of million dollars and does not include the loss of market capitalization and reputation. Since 2000, drug manufacturers have lost more than USD 3 billion for drug safety violations. The reason behind non-compliance is quite diverse and spread throughout people, process, and technology. Compliance is an evolving domain, and pharma companies have been prolonged to adapt to any major changes in regulations.


Here are some emerging trends in non-compliance.


Data Integrity


Fifteen years ago, when FDA started issuing warning letters for data integrity warning letters for identified failures in computer system validation, failure to review the laboratory computer systems audit trails, failure to maintain the electronic records, and failure to investigate their disappearance — the volume of warning letters containing a violation of data integrity have grown to 80 percent of all letters issued.


Cross Contamination


Cross-contamination has been one of the most debated compliance topics in the past few years. 


The industry is slowly adopting HBELs (Health-Based Exposure Limits) since EMA (European Medicines Agency) had published its Guideline on setting the health-based exposure limits for use in the risk identification in the manufacture of various medicinal products in shared facilities. Regulators are looking not only for science-based cleaning acceptance limits but also for the Statistics based alert limits keeping cleaning process capability in mind.


Release Testing


Releasing a drug product without a good assessment of the drug product’s quality leads to this kind of issue in the warning letter. Nearly one-fifth of all compliance issues are because of the incorrect or immature release of the product.


Slow Adoption of Technology in Pharmaceuticals


Conventionally, the Pharma industry has been very slow in adopting newer technologies compared to some of the other manufacturing industries like oil & gas, mining, and automobiles. This is usually attributed to the industry’s regulated nature and a lack of strong IT leadership.


Most production and compliance systems are still paper-based and suboptimal. As per a survey, 90 percent of the drug production facilities don’t use any computerized systems for compliance management.


See also: Top Healthcare Compliance Solution Companies


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of ADCs

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development
Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/what-is-the-role-of-technology-in-solving-fda-compliance-challenges-nwid-159.html